Oliver Soehnlein is Director of the Institute of Experimental Pathology at the Westfälische Wilhelms-University (WWU), Münster, DE in Münster holds a guest professorship for inflammation physiology at the Karolinska Institutet, Stockholm, Sweden.
He received his M.D. in 2004 from the Friedrich-Alexander University of Erlangen, Germany, and his Ph.D. from the Karolinska Institute in 2008. Oliver Soehnlein’s research focuses on understanding the role of myeloid cells in vascular inflammation. Based on this understanding he aims at designing tailored therapeutic approaches.
